for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Rhoen Klinikum AG

RHKG.DE

Latest Trade

19.66EUR

Change

-0.30(-1.50%)

Volume

3,121

Today's Range

19.66

 - 

19.90

52 Week Range

18.90

 - 

27.40

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
19.96
Open
19.72
Volume
3,121
3M AVG Volume
0.31
Today's High
19.90
Today's Low
19.66
52 Week High
27.40
52 Week Low
18.90
Shares Out (MIL)
66.94
Market Cap (MIL)
1,342.60
Forward P/E
35.59
Dividend (Yield %)
1.10

Next Event

Q3 2019 Rhoen Klinikum AG Earnings Release

Latest Developments

More

Rhön-Klinikum H1 Net Profit Up At EUR 20.5 Mln

Rhoen-Klinikum Confirms 2019 Guidance At AGM

Rhoen Klinikum Q1 EBITDA Up 4 Pct To EUR 28.7 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Rhoen Klinikum AG

Rhoen Klinikum AG is a Germany-based provider of health care services. It operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.

Industry

Healthcare Facilities

Contact Info

Schlossplatz 1

+49.9.771650

https://www.rhoen-klinikum-ag.com/

Executive Leadership

Eugen Muench

Chairman of the Supervisory Board

Stephan Holzinger

Chairman of the Management Board, Chief Executive Officer

Wolfgang Muendel

Second Deputy Chairman of the Supervisory Board

Georg Schulze-Ziehaus

First Deputy Chairman of the Supervisory Board, Employee Representative

Bernd Griewing

Member of the Management Board, Chief Medical Officer

Key Stats

3.38 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

1.2K

2017

1.2K

2018

1.2K

2019(E)

1.3K
EPS (EUR)

2016

0.840

2017

0.550

2018

0.730

2019(E)

0.563
Price To Earnings (TTM)
25.62
Price To Sales (TTM)
1.07
Price To Book (MRQ)
1.18
Price To Cash Flow (TTM)
11.29
Total Debt To Equity (MRQ)
8.85
LT Debt To Equity (MRQ)
8.75
Return on Investment (TTM)
4.54
Return on Equity (TTM)
3.52

Latest News

Latest News

BRIEF-Rhoen Klinikum FY Net Profit Of 36.7 Million Euros

* FOR CURRENT FINANCIAL YEAR 2018 WE EXPECT REVENUES IN AMOUNT OF EURO 1.24 BILLION PLUS/MINUS 5 PERCENT

BRIEF-Rhön-Klinikum, UKGM, Federal State Of Hesse And Universities Of Giessen And Marburg Sign Agreement In Separate Accounting

* DGAP-NEWS: RHÖN-KLINIKUM AG, UKGM, FEDERAL STATE OF HESSE AND UNIVERSITIES OF GIESSEN AND MARBURG SIGN AGREEMENT IN SEPARATE ACCOUNTING Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Rhoen-Klinikum Q3 EBITDA down at 27.4 million euros

* INTERIM REPORT FOR THE THIRD QUARTER OF 2017: RHÖN-KLINIKUM AG ON THE RIGHT TRACK - ACTION PLAN FOR IMPROVING PROFITABILITY SUCCESSFULLY COMMENCED - FORECAST FOR 2017 CONFIRMED

BRIEF-Rhoen Klinikum H1 EBITDA at 50.2 million euros

* OUTLOOK FOR 2017: REVENUES BETWEEN EURO 1.20 BILLION AND EURO 1.23 BILLION, EBITDA BETWEEN EURO 85 MILLION AND EURO 105 MILLION

BRIEF-Rhoen Klinikum sees FY revenues of EUR 1.20 bln - 1.23 bln

* FOR CURRENT FINANCIAL YEAR 2017 COMPANY EXPECTS REVENUES OF EURO 1.20 BILLION TO EURO 1.23 BILLION AND EBITDA OF EURO 85 MILLION TO EURO 105 MILLION

BRIEF-Asklepios owner ups stake in Rhoen-Klinikum to 25.1 percent

* Says in filing that Asklepios owner Broermann's holding rises to 25.1 percent from 20.2 percent Source text for Eikon: Further company coverage:

BRIEF-Rhoen Klinikum, UKGM, Federal State of Hesse and Universities of Giessen and Marburg achieve agreement in separate accounting

* SAYS UKGM, FEDERAL STATE OF HESSE AND UNIVERSITIES OF GIESSEN AND MARBURG ACHIEVE GROUND-BREAKING AGREEMENT IN SEPARATE ACCOUNTING

BRIEF-Rhön-Klinikum posts Q1 EBITDA of eur 25.5 million

* Interim report for the first quarter of 2017: new board of management tackles main tasks - focus on raising profitability and putting campus concept into practice - outlook for 2017

BRIEF-Rhoen Klinikum proposes dividend of 0.35 euro per share

* Outlook for 2017: revenues between 1.20 billion and 1.23 billion euros ($1.28 billion - $1.31 billion) Source text for Eikon: Further company coverage: ($1 = 0.9392 euros) (Gdynia Newsroom)

BRIEF-Asklepios owner hikes stake in Rhoen-Klinikum to more than 20 pct

* Says Asklepios owner Broermann's holding in Rhoen rises to 20.2 percent from 17.6 percent Source text for Eikon: Further company coverage:

BRIEF-Rhoen Klinikum FY net consolidated profit was at EUR 58.6 mln

* FY corporate revenues stood at 1.18 billion euros ($1.25 billion) with earnings before interest, taxes, depreciation and amortisation (EBITDA) amounting to 156.9 million euros

BRIEF-Rhoen-Klinikum reduces size of management board

* To reduce size of management board from five to three members by revoking appointment of Martin Menger (operative business) and Jens-Peter Neumann (finance) to management board

Rhoen Klinikum's management board to be reduced

A committee of Rhoen Klinikum's supervisory board on Thursday proposed to cut the number of management board members and remove two key executives, finance chief Jens-Peter Neumann and chief operating officer Martin Menger.

BRIEF-Rhoen Klinikum: removal of management board members Martin Menger and Jens-Peter Neumann

* Personnel committee of the supervisory board recommends reducing the management board by removing management board members Martin Menger and Jens-Peter Neumann

BRIEF-Rhoen Klinikum: value adjustment in connection with financial investment in MIT GmbH

* Value adjustment in connection with financial investment in mit gmbh in amount of approx. 35.5 million euros ($37.66 million)

Rhoen Klinikum appoints Stephan Holzinger as chief executive

Rhoen Klinikum appointed Stephan Holzinger as its chief executive on Friday for a five-year term from Feb. 1.

BRIEF-Rhoen Klinikum says plans to appoint Stephan Holzinger as new CEO

* dgap-adhoc: rhön-klinikum ag: decision making process of supervisory board of rhön- klinikum concerning reorganization of management board

BRIEF-Rhoen Klinikum: significant structural burdens on FY 2017 results

* Management board expects since today significant structural burdens on results in a range of low to middle two digit millions for current financial year 2017

BRIEF-Rhoen Klinikum sees regulatory obstacles, confirms outlook

* EBITDA in amount of euro 131.5 million includes dissolving provisions of euro 41 million

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up